These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18422867)

  • 1. Procalcitonin is a valuable prognostic marker in ARDS caused by community-acquired pneumonia.
    Tseng JS; Chan MC; Hsu JY; Kuo BI; Wu CL
    Respirology; 2008 Jun; 13(4):505-9. PubMed ID: 18422867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia.
    Kasamatsu Y; Yamaguchi T; Kawaguchi T; Tanaka N; Oka H; Nakamura T; Yamagami K; Yoshioka K; Imanishi M
    Respirology; 2012 Feb; 17(2):330-6. PubMed ID: 22059525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of procalcitonin level in community-acquired pneumonia in the ED.
    Park JH; Wee JH; Choi SP; Oh SH
    Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
    Ugajin M; Yamaki K; Hirasawa N; Yagi T
    Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
    España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
    J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin kinetics in Legionella pneumophila pneumonia.
    de Jager CP; de Wit NC; Weers-Pothoff G; van der Poll T; Wever PC
    Clin Microbiol Infect; 2009 Nov; 15(11):1020-5. PubMed ID: 19438643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ability of procalcitonin to predict bacteremia in patients with community acquired pneumonia].
    Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Parejo Miguez R; Flores Chacartegui M; Gallardo Schall P
    Med Clin (Barc); 2014 Apr; 142(7):285-92. PubMed ID: 24120103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of procalcitonin and IL-6 in discriminating between septic and non-septic causes of ALI/ARDS: a prospective observational study.
    Tsantes A; Tsangaris I; Kopterides P; Kapsimali V; Antonakos G; Zerva A; Kalamara E; Bonovas S; Tsaknis G; Vrigou E; Maniatis N; Dima K; Armaganidis A
    Clin Chem Lab Med; 2013 Jul; 51(7):1535-42. PubMed ID: 23314554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic value of procalcitonin in community-acquired pneumonia.
    Horie M; Ugajin M; Suzuki M; Noguchi S; Tanaka W; Yoshihara H; Kawakami M; Kichikawa Y; Sakamoto Y
    Am J Med Sci; 2012 Jan; 343(1):30-5. PubMed ID: 22207498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.
    Lindstrom ST; Wong EK
    Intern Med J; 2014 Apr; 44(4):390-7. PubMed ID: 24528892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia.
    Lee JY; Hwang SJ; Shim JW; Jung HL; Park MS; Woo HY; Shim JY
    Korean J Lab Med; 2010 Aug; 30(4):406-13. PubMed ID: 20805714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
    Zhydkov A; Christ-Crain M; Thomann R; Hoess C; Henzen C; Werner Z; Mueller B; Schuetz P;
    Clin Chem Lab Med; 2015 Mar; 53(4):559-66. PubMed ID: 25014522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum procalcitonin is a valuable diagnostic marker in acute exacerbation of interstitial pneumonia.
    Nagata K; Tomii K; Otsuka K; Tachikawa R; Nakagawa A; Otsuka K; Takeshita J; Tanaka K; Matsumoto T; Monden K; Kawamura T; Tamai K
    Respirology; 2013 Apr; 18(3):439-46. PubMed ID: 23163578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin.
    Brunkhorst FM; Eberhard OK; Brunkhorst R
    Crit Care Med; 1999 Oct; 27(10):2172-6. PubMed ID: 10548201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.
    Müller B; Harbarth S; Stolz D; Bingisser R; Mueller C; Leuppi J; Nusbaumer C; Tamm M; Christ-Crain M
    BMC Infect Dis; 2007 Mar; 7():10. PubMed ID: 17335562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial inflammatory biomarkers of the severity, course and outcome of late onset acute respiratory distress syndrome in critically ill patients with or at risk for the syndrome after new-onset fever.
    Hoeboer SH; Groeneveld AB; van der Heijden M; Oudemans-van Straaten HM
    Biomark Med; 2015; 9(6):605-16. PubMed ID: 26079964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial quantification of procalcitonin (PCT) predicts clinical outcome and prognosis in patients with community-acquired pneumonia (CAP).
    Tamura M; Watanabe M; Nakajima A; Kurai D; Ishii H; Takata S; Nakamoto K; Sohara E; Honda K; Nakamura M; Inui T; Wada H; Takizawa H; Goto H
    J Infect Chemother; 2014 Feb; 20(2):97-103. PubMed ID: 24462441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study.
    Bloos F; Marshall JC; Dellinger RP; Vincent JL; Gutierrez G; Rivers E; Balk RA; Laterre PF; Angus DC; Reinhart K; Brunkhorst FM
    Crit Care; 2011; 15(2):R88. PubMed ID: 21385367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of procalcitonin in community-acquired pneumonia.
    Schuetz P; Suter-Widmer I; Chaudri A; Christ-Crain M; Zimmerli W; Mueller B;
    Eur Respir J; 2011 Feb; 37(2):384-92. PubMed ID: 20595156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of serum procalcitonin levels in pulmonary tuberculosis.
    Ugajin M; Miwa S; Shirai M; Ohba H; Eifuku T; Nakamura H; Suda T; Hayakawa H; Chida K
    Eur Respir J; 2011 Feb; 37(2):371-5. PubMed ID: 20530033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.